Technology
Health
Medical

Cytosorbents

$4.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (0.63%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Cytosorbents and other stocks, options, ETFs, and crypto commission-free!

About CTSO

CytoSorbents Corp. engages in the research and development of blood purification technology for the reduction of deadly uncontrolled inflammation in hospitalized patients. Its product include CytoSorb, ContrastSorb, HemoDefend, VetResQ, and DrugSorb. Read More The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.

Employees
125
Headquarters
Monmouth Junction, New Jersey
Founded
2002
Market Cap
155.05M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
431.29K
High Today
$4.87
Low Today
$4.34
Open Price
$4.85
Volume
306.55K
52 Week High
$14.95
52 Week Low
$3.68

Collections

Technology
Health
Medical
Research And Development
US
North America

CTSO Earnings

-$0.19
-$0.16
-$0.12
-$0.09
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.14 per share
Actual
-$0.11 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.